Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

David Feeny

Showing results (31-40 of 134) with videos related to

Pageof 14
Sort By:
Expert Review of Pharmacoeconomics & Outcomes Research|June 16, 2010
QALY weights for neurosensory impairments in pediatric economic evaluations: case studies and a critiqueScott D Grosse, Lisa A Prosser, Keiko Asakawa, et al.
Population Health Metrics|May 1, 2010
Comparing population health in the United States and CanadaDavid Feeny, Mark S Kaplan, Nathalie Huguet, et al.
Patient Related Outcome Measures|December 4, 2012
Patient-reported outcome 2 years after lung transplantation: does the underlying diagnosis matter?Maria Jose Santana, David Feeny, Sunita Ghosh, et al.
Quality of Life Research : an International Journal of Quality of Life Aspects of Treatment, Care and Rehabilitation|March 12, 2009
The construct validity of the Health Utilities Index Mark 3 in assessing mental health in population health surveysDavid Feeny, Nathalie Huguet, Bentson H McFarland, et al.
Medical Decision Making : an International Journal of the Society for Medical Decision Making|August 2, 2002
How robust is the Health Utilities Index Mark 2 utility function?Qinan Wang, William Furlong, David Feeny, et al.
Canadian Respiratory Journal|October 24, 2009
Improvement in health-related quality of life after lung transplantationMaria-Jose Santana, David Feeny, Katherine Jackson, et al.
Social Science & Medicine (1982)|June 17, 2009
Do the determinants of health differ between people living in the community and in institutions?Keiko Asakawa, David Feeny, Ambikaipakan Senthilselvan, et al.
Journal of Clinical Epidemiology|March 25, 2008
Health Utilities Index Mark 3 showed valid in Alzheimer disease, arthritis, and cataractsKeiko Asakawa, Darryl Rolfson, Ambikaipakan Senthilselvan, et al.
European Journal of Cardiovascular Prevention and Rehabilitation : Official Journal of the European Society of Cardiology, Working Groups on Epidemiology & Prevention and Cardiac Rehabilitation and Exercise Physiology|September 19, 2008
Community or patient preferences for cost-effectiveness of cardiac rehabilitation: does it matter?Neil Oldridge, William Furlong, Anthony Perkins, et al.
Quality of Life Research : an International Journal of Quality of Life Aspects of Treatment, Care and Rehabilitation|March 21, 2006
Analyzing oncology clinical trial data using the Q-TWiST method: clinical importance and sources for health state preference dataDennis A Revicki, David Feeny, Timothy L Hunt, et al.
Pageof 14

Showing results (31-40 of 134) with videos related to

Sort By:
Pageof 14
Expert Review of Pharmacoeconomics & Outcomes Research|June 16, 2010
QALY weights for neurosensory impairments in pediatric economic evaluations: case studies and a critiqueScott D Grosse, Lisa A Prosser, Keiko Asakawa, et al.
Population Health Metrics|May 1, 2010
Comparing population health in the United States and CanadaDavid Feeny, Mark S Kaplan, Nathalie Huguet, et al.
Patient Related Outcome Measures|December 4, 2012
Patient-reported outcome 2 years after lung transplantation: does the underlying diagnosis matter?Maria Jose Santana, David Feeny, Sunita Ghosh, et al.
Quality of Life Research : an International Journal of Quality of Life Aspects of Treatment, Care and Rehabilitation|March 12, 2009
The construct validity of the Health Utilities Index Mark 3 in assessing mental health in population health surveysDavid Feeny, Nathalie Huguet, Bentson H McFarland, et al.
Medical Decision Making : an International Journal of the Society for Medical Decision Making|August 2, 2002
How robust is the Health Utilities Index Mark 2 utility function?Qinan Wang, William Furlong, David Feeny, et al.
Canadian Respiratory Journal|October 24, 2009
Improvement in health-related quality of life after lung transplantationMaria-Jose Santana, David Feeny, Katherine Jackson, et al.
Social Science & Medicine (1982)|June 17, 2009
Do the determinants of health differ between people living in the community and in institutions?Keiko Asakawa, David Feeny, Ambikaipakan Senthilselvan, et al.
Journal of Clinical Epidemiology|March 25, 2008
Health Utilities Index Mark 3 showed valid in Alzheimer disease, arthritis, and cataractsKeiko Asakawa, Darryl Rolfson, Ambikaipakan Senthilselvan, et al.
European Journal of Cardiovascular Prevention and Rehabilitation : Official Journal of the European Society of Cardiology, Working Groups on Epidemiology & Prevention and Cardiac Rehabilitation and Exercise Physiology|September 19, 2008
Community or patient preferences for cost-effectiveness of cardiac rehabilitation: does it matter?Neil Oldridge, William Furlong, Anthony Perkins, et al.
Quality of Life Research : an International Journal of Quality of Life Aspects of Treatment, Care and Rehabilitation|March 21, 2006
Analyzing oncology clinical trial data using the Q-TWiST method: clinical importance and sources for health state preference dataDennis A Revicki, David Feeny, Timothy L Hunt, et al.
Pageof 14